Huadong Medicine Co., Ltd (SHE:000963)
China · Delayed Price · Currency is CNY 36.12
+0.18 (0.50%)
Apr 8, 2026, 12:24 PM CST
Huadong Medicine Revenue
Huadong Medicine had revenue of 10.99B CNY in the quarter ending September 30, 2025, with 4.53% growth. This brings the company's revenue in the last twelve months to 43.09B, up 3.32% year-over-year. In the year 2024, Huadong Medicine had annual revenue of 41.91B with 3.16% growth.
Revenue (ttm)
43.09B
Revenue Growth
+3.32%
P/S Ratio
1.46
Revenue / Employee
2.36M
Employees
18,265
Market Cap
62.88B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 41.91B | 1.28B | 3.16% |
| Dec 31, 2023 | 40.62B | 2.91B | 7.71% |
| Jan 1, 2023 | 37.71B | 3.15B | 9.12% |
| Jan 1, 2022 | 34.56B | 880.24M | 2.61% |
| Dec 31, 2020 | 33.68B | -1.76B | -4.97% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shanghai Fosun Pharmaceutical (Group) | 41.66B |
| Yunnan Baiyao Group Co.,Ltd | 41.19B |
| China Resources Sanjiu Medical & Pharmaceutical | 31.60B |
| Humanwell Healthcare (Group) | 23.96B |
| Zhejiang NHU Company | 22.47B |
| Beijing Tongrentang | 17.26B |
| Changchun High-Tech Industry (Group) | 12.88B |
| Dong-E-E-Jiao | 6.70B |
Huadong Medicine News
- 4 weeks ago - CARsgen Therapeutics Announces 2025 Annual Results - Benzinga